Sino Biopharmaceutical Limited
SBMFF
$0.9891
$0.03914.12%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -0.48% | -17.21% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.48% | -17.21% | |||
| Cost of Revenue | -0.48% | -11.41% | |||
| Gross Profit | -0.48% | -18.48% | |||
| SG&A Expenses | -0.48% | -21.54% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -0.48% | 30.17% | |||
| Total Operating Expenses | -0.48% | -7.91% | |||
| Operating Income | -0.48% | -50.47% | |||
| Income Before Tax | -0.48% | -53.44% | |||
| Income Tax Expenses | 0.48% | -119.96% | |||
| Earnings from Continuing Operations | -0.48% | -39.82% | |||
| Earnings from Discontinued Operations | 0.48% | -101.68% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 0.48% | 18.84% | |||
| Net Income | -0.48% | -83.82% | |||
| EBIT | -0.48% | -50.47% | |||
| EBITDA | -1.00% | -44.18% | |||
| EPS Basic | -5.26% | -83.19% | |||
| Normalized Basic EPS | -6.25% | -38.46% | |||
| EPS Diluted | -5.26% | -83.19% | |||
| Normalized Diluted EPS | -6.25% | -38.46% | |||
| Average Basic Shares Outstanding | 0.00% | -1.25% | |||
| Average Diluted Shares Outstanding | 0.00% | -1.25% | |||
| Dividend Per Share | 0.00% | 36.84% | |||
| Payout Ratio | -- | -- | |||